fludeoxyglucose f18

Generic: fludeoxyglucose f18

Labeler: the methodist hospital research institute
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name fludeoxyglucose f18
Generic Name fludeoxyglucose f18
Labeler the methodist hospital research institute
Dosage Form INJECTION, SOLUTION
Routes
INTRAVENOUS
Active Ingredients

fludeoxyglucose f-18 .3 Ci/mL

Manufacturer
The Methodist Hospital Research Institute

Identifiers & Regulatory

Product NDC 69864-001
Product ID 69864-001_c961907a-db84-c6f2-e053-2995a90aefd2
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA203904
Listing Expiration 2026-12-31
Marketing Start 2012-04-23

Pharmacologic Class

Established (EPC)
radioactive diagnostic agent [epc]
Mechanism of Action
radiopharmaceutical activity [moa]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 69864001
Hyphenated Format 69864-001

Supplemental Identifiers

UNII
0Z5B2CJX4D
NUI
N0000177914 N0000000205

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name fludeoxyglucose f18 (source: ndc)
Generic Name fludeoxyglucose f18 (source: ndc)
Application Number ANDA203904 (source: ndc)
Routes
INTRAVENOUS
source: ndc

Resolved Composition

Strengths
  • .3 Ci/mL
source: ndc
Packaging
  • 30 mL in 1 VIAL, MULTI-DOSE (69864-001-30)
source: ndc

Packages (1)

69864-001-30 30 mL in 1 VIAL, MULTI-DOSE (69864-001-30)

Ingredients (1)

fludeoxyglucose f-18 (.3 Ci/mL)

Linked Drug Pages (1)

Fludeoxyglucose F18 ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "c961907a-db84-c6f2-e053-2995a90aefd2", "openfda": {"nui": ["N0000177914", "N0000000205"], "unii": ["0Z5B2CJX4D"], "spl_set_id": ["195d1b07-5669-247f-e054-00144ff8d46c"], "pharm_class_epc": ["Radioactive Diagnostic Agent [EPC]"], "pharm_class_moa": ["Radiopharmaceutical Activity [MoA]"], "manufacturer_name": ["The Methodist Hospital Research Institute"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "30 mL in 1 VIAL, MULTI-DOSE (69864-001-30)", "package_ndc": "69864-001-30", "marketing_start_date": "20120423"}], "brand_name": "Fludeoxyglucose F18", "product_id": "69864-001_c961907a-db84-c6f2-e053-2995a90aefd2", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Radioactive Diagnostic Agent [EPC]", "Radiopharmaceutical Activity [MoA]"], "product_ndc": "69864-001", "generic_name": "Fludeoxyglucose F18", "labeler_name": "The Methodist Hospital Research Institute", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Fludeoxyglucose F18", "active_ingredients": [{"name": "FLUDEOXYGLUCOSE F-18", "strength": ".3 Ci/mL"}], "application_number": "ANDA203904", "marketing_category": "ANDA", "marketing_start_date": "20120423", "listing_expiration_date": "20261231"}